These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Deregulated Ca2+ cycling underlies the development of arrhythmia and heart disease due to mutant obscurin. Hu LR, Ackermann MA, Hecker PA, Prosser BL, King B, O'Connell KA, Grogan A, Meyer LC, Berndsen CE, Wright NT, Jonathan Lederer W, Kontrogianni-Konstantopoulos A. Sci Adv; 2017 Jun; 3(6):e1603081. PubMed ID: 28630914 [Abstract] [Full Text] [Related]
13. Identification and characterization of self-association domains on small ankyrin 1 isoforms. Subramaniam J, Yang P, McCarthy MJ, Cunha SR. J Mol Cell Cardiol; 2020 Feb 29; 139():225-237. PubMed ID: 32035138 [Abstract] [Full Text] [Related]
15. Essential role of obscurin kinase-1 in cardiomyocyte coupling via N-cadherin phosphorylation. Wang L, Tsakiroglou P, Gonzales R, Cho S, Li A, Dos Remedios C, Wright N, Kontrogianni-Konstantopoulos A. JCI Insight; 2024 Feb 08; 9(3):. PubMed ID: 38127465 [Abstract] [Full Text] [Related]
16. A novel missense mutation in obscurin gene in a Chinese consanguineous family with left ventricular noncompaction. Dong XQ, Qin PP, Zhang D, Zhang QY, Qu Y, Zhao L, Lu YT, Hu YX, Yang CX, Liu XC, Liu YX, Zhou XL. J Geriatr Cardiol; 2022 Jul 28; 19(7):531-538. PubMed ID: 35975021 [Abstract] [Full Text] [Related]
17. Murine obscurin and Obsl1 have functionally redundant roles in sarcolemmal integrity, sarcoplasmic reticulum organization, and muscle metabolism. Blondelle J, Marrocco V, Clark M, Desmond P, Myers S, Nguyen J, Wright M, Bremner S, Pierantozzi E, Ward S, Estève E, Sorrentino V, Ghassemian M, Lange S. Commun Biol; 2019 Jul 28; 2():178. PubMed ID: 31098411 [Abstract] [Full Text] [Related]
18. Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice. Flenner F, Geertz B, Reischmann-Düsener S, Weinberger F, Eschenhagen T, Carrier L, Friedrich FW. J Physiol; 2017 Jun 15; 595(12):3987-3999. PubMed ID: 28090637 [Abstract] [Full Text] [Related]
19. Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic Cardiomyopathy. Coppini R, Mazzoni L, Ferrantini C, Gentile F, Pioner JM, Laurino A, Santini L, Bargelli V, Rotellini M, Bartolucci G, Crocini C, Sacconi L, Tesi C, Belardinelli L, Tardiff J, Mugelli A, Olivotto I, Cerbai E, Poggesi C. Circ Heart Fail; 2017 Mar 15; 10(3):. PubMed ID: 28255011 [Abstract] [Full Text] [Related]
20. Proteomic analysis of dystrophin deficiency and associated changes in the aged mdx-4cv heart model of dystrophinopathy-related cardiomyopathy. Murphy S, Dowling P, Zweyer M, Mundegar RR, Henry M, Meleady P, Swandulla D, Ohlendieck K. J Proteomics; 2016 Aug 11; 145():24-36. PubMed ID: 26961938 [Abstract] [Full Text] [Related] Page: [Next] [New Search]